Want to see SG:A50 full AI Analyst Report?
A50 Stock Chart & Stats
S$0.06
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.06
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.04 - S$0.07
Previous CloseN/A
Volume460.80K
Average Volume (3M)2.14M
Market Cap
S$1.40B
Enterprise ValueS$2.45B
Total Cash (Recent Filing)S$103.20M
Total Debt (Recent Filing)S$1.11B
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Aug 31, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding26,443,615,000
10 Day Avg. Volume2,062,170
30 Day Avg. Volume2,143,033
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.41
Price to Sales (P/S)2.88
P/FCF Ratio33.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)S$455.90M
Bulls Say, Bears Say
Bulls Say
High Gross MarginA sustained gross margin near 75% indicates the business captures significant value from clinical and ancillary services. Over 2-6 months this margin buffers operating volatility, supports reinvestment in specialist capabilities and labs, and helps preserve profitability if SG&A is reined in.
Specialized Women’s & Children’s Healthcare FranchiseA focused specialty mix (obstetrics, gynaecology, fertility, paediatrics) yields recurring and referral-driven demand, differentiated clinical expertise and package-based revenue streams. This specialization supports defensible market position and steady patient flows over the medium term.
Some Ability To Convert Earnings To CashA FCF-to-net-income ratio above 0.5 indicates the company can translate a material portion of accounting profit into cash. Even with stressed cash trends, this conversion ability supports debt servicing and selective reinvestment if operational performance stabilizes.
Bears Say
High Financial LeverageA D/E of 2.38 creates elevated fixed obligations and reduces financial flexibility. Over several months higher leverage increases refinancing and interest-rate sensitivity, constrains capital allocation to growth or capex, and raises downside risk if volumes or margins slip further.
Negative Net ProfitabilityA negative net margin shows the core operations are not generating accounting profits after expenses and financing. Persisting losses erode equity, limit internal funding for expansion, and can depress stakeholder confidence unless margins and cost structures are meaningfully improved.
Severely Weakened Free Cash Flow GrowthA >600% drop in FCF growth and low OCF-to-net-income ratio signal acute cash generation stress. This reduces liquidity for operations, heightens refinancing risk given high leverage, and limits capacity to invest in service expansion or absorb cyclical demand shocks.
Thomson Medical Group Ltd. News
A50 FAQ
What was Thomson Medical Group Ltd.’s price range in the past 12 months?
Thomson Medical Group Ltd. lowest share price was S$0.04 and its highest was S$0.07 in the past 12 months.
What is Thomson Medical Group Ltd.’s market cap?
Thomson Medical Group Ltd.’s market cap is S$1.40B.
When is Thomson Medical Group Ltd.’s upcoming earnings report date?
Thomson Medical Group Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 51 days.
How were Thomson Medical Group Ltd.’s earnings last quarter?
Thomson Medical Group Ltd. released its earnings results on Feb 11, 2026. The company reported S$0 earnings per share for the quarter, the consensus estimate of N/A by S$0.
Is Thomson Medical Group Ltd. overvalued?
According to Wall Street analysts Thomson Medical Group Ltd.’s price is currently Overvalued.
Does Thomson Medical Group Ltd. pay dividends?
Thomson Medical Group Ltd. pays a N/A dividend of <S$0.001 which represents an annual dividend yield of N/A. See more information on Thomson Medical Group Ltd. dividends here
What is Thomson Medical Group Ltd.’s EPS estimate?
Thomson Medical Group Ltd.’s EPS estimate is 0.
How many shares outstanding does Thomson Medical Group Ltd. have?
Thomson Medical Group Ltd. has 26,443,615,000 shares outstanding.
What happened to Thomson Medical Group Ltd.’s price movement after its last earnings report?
Thomson Medical Group Ltd. reported an EPS of S$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 1.639%.
Which hedge fund is a major shareholder of Thomson Medical Group Ltd.?
Currently, no hedge funds are holding shares in SG:A50
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Thomson Medical Group Ltd.
Operating as an investment holding company, Thomson Medical Group Limited delivers healthcare services specifically tailored for women and children across Singapore, Malaysia, and Vietnam. Its core assets include the Thomson Medical Centre, alongside an extensive network of affiliated medical clinics and healthcare facilities. The group's service portfolio encompasses immediate care solutions, covering basic resuscitation, ECG, vaccinations, intravenous fluid and antibiotic treatments, minor surgeries and procedures, wound management, and essential diagnostic imaging like X-rays and laboratory tests. Additionally, it provides comprehensive health screening, aesthetic and dermatological services, pain and rehabilitation management, and traditional herbal tea offerings. Furthermore, Thomson Medical Group specializes in a broad spectrum of medical areas. These include women's and children's health, fertility and family planning, ophthalmology, general surgery, urology, preventive health, healthy aging, advanced diagnostic imaging, breast care, cardiology, respiratory and critical care, endocrinology, dermatology, day surgery, general surgical care, counselling, therapy, Traditional Chinese Medicine (TCM), and specialized care for bone, joint, gynecological oncology, dental, and spine conditions. The company's diverse range of products and services are marketed under well-known brands such as Thomson Women's Clinic, Thomson Fertility Centre, Thomson Paediatric Clinic, Thomson Specialists, Thomson Chinese Medicine, Thomson Surgical Centre, Thomson Dental Centre, Thomson Hospital Kota Damansara, TMC Fertility, TMC Care Pharmacy, FV Hospital, and FV Saigon Clinic. Established in 1979, Thomson Medical Group Limited is headquartered in Singapore.
Technical Analysis
Cordlife Group
―
Raffles Medical Group
―
Asiamedic Limited
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―
Options Prices
Currently, No data available
---